Asbestos Research Today is a free monthly online journal that collates and summarizes the latest research about Asbestos, including details on mesothelioma, lung disease, dangers, effects, risks.

Volume 5 (2008), Issue 7 (July)

1. Multiple mechanisms of telomere maintenance exist and differentially affect clinical outcome in diffuse malignant peritoneal mesothelioma.
   Clin Cancer Res, 14(13): 4134-40. [Abstract] [Full-text]
2. Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma.
   Br J Cancer, 99(1): 44-50. [Abstract] [Full-text]
3. Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials.
   Br J Cancer, 99(1): 51-6. [Abstract] [Full-text]
4. Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: final report of a phase II trial.
   J Clin Oncol, 26(21): 3567-72. [Abstract] [Full-text]

© 2004-2008 Asbestos Research Today. All Rights Reserved.